Literature DB >> 10714473

Improving patient compliance with asthma therapy.

K R Chapman1, L Walker, S Cluley, L Fabbri.   

Abstract

Patients fail to comply with asthma medication for a variety of reasons. These range from physical inability to use an inhaler, through simple forgetfulness, to a conscious decision not to use medication as prescribed due to internal or cultural health beliefs or socioeconomic factors. In some patients, poor self-care because of deep-rooted psychological factors (i.e. factors of which patients have only limited awareness) can affect compliance. Poor doctor-patient communication can be the cause in many other individuals. Thus, there is no single solution that will improve compliance in all patients. Simplifying the regimen or providing memory aids will be sufficient for some patients, while education or psychological counselling will be more appropriate for others. Doctors can also use a range of communication skills to improve the way in which they present information, motivate patients and reinforce progress. These approaches, plus respect for patients' health beliefs and involving them in treatment decisions, can help foster an atmosphere of mutual responsibility and concordance over medicine taking.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10714473     DOI: 10.1053/rmed.1999.0667

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  27 in total

1.  Funhaler spacer: improving adherence without compromising delivery.

Authors:  P M Watt; B Clements; S G Devadason; G M Chaney
Journal:  Arch Dis Child       Date:  2003-07       Impact factor: 3.791

2.  Health literacy, language, and ethnicity-related factors in newcomer asthma patients to Canada: a qualitative study.

Authors:  Iraj Poureslami; Irving Rootman; Mary M Doyle-Waters; Laura Nimmon; J Mark Fitzgerald
Journal:  J Immigr Minor Health       Date:  2011-04

3.  Factors associated with nonresponse to a computer-tailored asthma management program for urban adolescents with asthma.

Authors:  C L M Joseph; S L Havstad; D Johnson; J Saltzgaber; E L Peterson; K Resnicow; D R Ownby; A P Baptist; C C Johnson; V J Strecher
Journal:  J Asthma       Date:  2010-08       Impact factor: 2.515

4.  Asthma control in Canada remains suboptimal: the Reality of Asthma Control (TRAC) study.

Authors:  J Mark FitzGerald; Louis-Philipe Boulet; R Andrew McIvor; Sabrina Zimmerman; Kenneth R Chapman
Journal:  Can Respir J       Date:  2006 Jul-Aug       Impact factor: 2.409

Review 5.  A systematic review of asthma and health literacy: a cultural-ethnic perspective in Canada.

Authors:  Iraj M Poureslami; Irving Rootman; Ellen Balka; Rajashree Devarakonda; James Hatch; J Mark Fitzgerald
Journal:  MedGenMed       Date:  2007-08-21

6.  Asthma control and management in the community: indices in 1997 compared with indices in 2002.

Authors:  Robert L Cowie; Margot F Underwood; Don D Sin; Heather M Sharpe; Neil R Bell; S F Paul Man
Journal:  Can Fam Physician       Date:  2006-06       Impact factor: 3.275

Review 7.  Asthma that is unresponsive to usual care.

Authors:  Kenneth R Chapman; Andrew McIvor
Journal:  CMAJ       Date:  2009-10-13       Impact factor: 8.262

8.  Usability and training differences between two personal insulin pumps.

Authors:  Noel E Schaeffer; Linda J Parks; Erik T Verhoef; Timothy S Bailey; Alan B Schorr; Trent Davis; Jean Halford; Becky Sulik
Journal:  J Diabetes Sci Technol       Date:  2014-10-14

Review 9.  Inhaled salmeterol/fluticasone propionate combination. A pharmacoeconomic review of its use in the management of asthma.

Authors:  A Markham; J C Adkins
Journal:  Pharmacoeconomics       Date:  2000-12       Impact factor: 4.981

10.  Evaluation of patient-reported outcomes and quality of life with the I-neb AAD system in patients with chronic obstructive pulmonary disease.

Authors:  Nicola Goodman; Mike Morgan; Kurt Nikander; Sarah Hinch; Steven Coughlin
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2010-04       Impact factor: 2.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.